Doug Lockyer

Doug left the firm at the close of the acquisition, his role complete. The final chart to the left shows projected revenues and sources for 2003. This chart was made in 2001, prior to the Genomic Solutions acquisition.

Since the acquisition, Genomic Solutions was itself acquired by Harvard Bioscience, and now runs as a wholly owned subsidiary. Performance form the Proteomics division has been robust, according to annual reports from Genomic Solutions and Harvard Bioscience, and one may presume, given that ProteoMetrics products such as RADARS features prominently in the product offering, that part of the growth in revenues for the group, from $40 M to nearly $90 M for 2003 has been contributed by ProteoMetrics software.